Cosmos Health Inc. (COSM) — Financial statements
Income statement, balance sheet, and cash flow for Cosmos Health Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 65↑19.9% | 54↑2.0% | 53↑6.0% | 50↓10.5% | 56 | |
| Cost of Revenue | 57↑14.5% | 50↑2.2% | 49↑10.4% | 44↓7.3% | 48 | |
| Gross Profit | 8↑83.1% | 4↓0.9% | 4↓27.0% | 6↓28.5% | 8 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.52↓2.6% | 0.53 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 16↑33.1% | 12↓51.8% | 24↑93.2% | 13↑8.0% | 12 | |
| Selling & Marketing Expenses | 0.15↓57.7% | 0.35↓70.5% | 1↑91.2% | 0.63↓14.0% | 0.73 | |
| SG&A Expenses | 16↑30.5% | 12↓52.7% | 26↑93.1% | 13↑6.7% | 12 | |
| Other Expenses | 8↑14.9% | 7↑1077.6% | 0.61↑225.3% | 0.19↓58.0% | 0.45 | |
| Operating Expenses | 25↑23.9% | 20↓24.2% | 26↑94.9% | 13↑4.4% | 13 | |
| Total Costs & Expenses | 82↑17.2% | 70↓7.0% | 75↑30.1% | 58↓4.9% | 61 | |
| Operating Results | ||||||
| Operating Income | -17↓6.4% | -16↑28.8% | -22↓192.1% | -7↓64.9% | -5 | |
| Depreciation & Amortization | 1↑9.6% | 1↑103.3% | 0.61↑225.3% | 0.19↓58.0% | 0.45 | |
| EBITDA | -15↓9.0% | -14↑18.4% | -17↓91.7% | -9↓133.2% | -4 | |
| EBIT | -17↓9.0% | -15↑14.2% | -18↓94.5% | -9↓113.0% | -4 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↓267.4% | -0.61↓197.6% | -0.20↑94.5% | -4↓5.5% | -4 | |
| Interest Income | 0.40↓2.5% | 0.41↓38.7% | 0.66↑180.5% | 0.24↑410.3% | 0.05 | |
| Interest Expense | 3↑159.1% | 1↑16.8% | 0.87↓78.1% | 4↑10.7% | 4 | |
| Non-Operating Income | -0.02↑95.1% | -0.37↑91.0% | -4↓357.1% | 2↑706.1% | -0.27 | |
| Other Income / Expenses | -3↓308.1% | -0.64↓119.4% | 3↑158.9% | -6↓68.4% | -3 | |
| Income Before Tax | -19↓18.3% | -16↑12.7% | -19↓42.0% | -13↓66.4% | -8 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.78↑579.8% | 0.11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -19↓18.3% | -16↑12.7% | -19↓34.1% | -14↓73.7% | -8 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -19↓18.3% | -16↑12.7% | -19↓34.1% | -14↓73.7% | -8 | |
| Bottom-Line Net Income | -19↑14.4% | -22↑13.2% | -26↑59.7% | -64↓310.0% | -16 | |
| EPS (Basic) | -0.63↑46.2% | -1.17↑45.6% | -2.15↑93.5% | -33.16↓39.7% | -23.74 | |
| EPS (Diluted) | -0.63↑46.2% | -1.17↑45.6% | -2.15↑93.5% | -33.16↓39.7% | -23.74 | |
| Weighted Average Shares | 30↑58.2% | 19↑60.0% | 12↑520.7% | 2↑193.5% | 0.66 | |
| Weighted Average Diluted Shares | 30↑58.2% | 19↑60.0% | 12↑520.7% | 2↑193.5% | 0.66 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.